Psychiatry and Neurology, Neurology · Tallahassee, FL
NPI
1699742767
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1401 Centerville Rd Ste 600
Tallahassee, FL, 32308
Phone (850) 878-8121
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
530 services
Medicare patients, 2024
312
Average age 68
Drug cost, 2024
$3.7M
7,075 prescriptions
Company payments, 2025
$1,196
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ricardo Ayala was code 99213 (office e&m - established), 293 times for 206 patients. In total Ricardo Ayala billed 530 services in 12 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 293 | 206 | $61.30 | $18K |
| 95816 Neurologic | Office | 109 | 108 | $302.83 | $33K |
| 99204 Office E&M - New | Office | 80 | 80 | $124.61 | $9,969 |
By year: 2022 $79K for 599 services; 2023 $71K for 589 services; 2024 $68K for 530 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ricardo Ayala prescribed most often to Medicare patients was Levetiracetam, with 813 prescriptions and refills. In total Ricardo Ayala wrote 7,075 Medicare prescriptions that cost $3.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 813 | 1,231 | 137 | $40K |
| Lacosamide Generic | 626 | 728 | 86 | $122K |
| Memantine Hcl Generic | 381 | 612 | 77 | $8,734 |
| Donepezil Hcl Generic | 363 | 673 | 84 | $4,175 |
| Topiramate Generic | 333 | 572 | 79 | $3,749 |
| Oxcarbazepine Generic | 271 | 385 | 43 | $28K |
| Emgality Pen Galcanezumab-Gnlm | 227 | 257 | 33 | $178K |
| Gabapentin Generic | 215 | 279 | 38 | $4,468 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 199 | 333 | 46 | $6,237 |
| Lamotrigine Generic | 195 | 286 | 33 | $3,647 |
| Fycompa Perampanel | 194 | 223 | 35 | $254K |
| Primidone Generic | 185 | 282 | 33 | $4,513 |
| Xcopri Cenobamate | 178 | 178 | 23 | $267K |
| Sertraline Hcl Generic | 174 | 285 | 46 | $1,301 |
| Phenobarbital Generic | 169 | 188 | 17 | $6,529 |
Brand drugs: 1,366 claims; generic drugs: 5,540 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ricardo Ayala $1,196 ($1,196 in general payments such as food, travel and fees) from 21 companies. The largest payer was UCB, Inc. with $190.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 9 | $190 |
| Pfizer Inc. PFE | 8 | $158 |
| TG Therapeutics, Inc. TGTX | 2 | $127 |
| Lilly USA, LLC LLY | 5 | $124 |
| SK Life Science, Inc. | 4 | $82.75 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $61.83 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $52.19 |
| Neurelis, Inc. | 3 | $52.16 |
| Abbvie Inc. ABBV | 2 | $47.76 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $45.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.